The purpose of this registry (NCT02880631) is to evaluate the effect of BAROSTIM THERAPY with
the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the
CE-Marked indication for resistant hypertension.
Device: BAROSTIM NEO™ System
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02880631
Ages eligible for Study
Genders eligible for Study
Accepts Healthy Volunteers
Has signed an EC approved informed consent form
Has been implanted with the BAROSTIM NEO system in the past 30 days
Systolic blood pressure greater than or equal to 140 mmHg, and
Resistance to maximally tolerated therapy with a diuretic and two other anti-hypertension medications
Bilateral carotid bifurcations located above the level of the mandible
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.